Uric acid excretion in North American and Southeast European children with obstructive sleep apnea

Sleep Medicine

Volumn 11, Issue 5, 2010, Pages 489-493

  Kaditis, Athanasios ^a   Gozal, David ^b,c   Snow, Ayelet B ^b   Kheirandish Gozal, Leila ^b,c   Alexopoulos, Emmanouel ^a   Varlami, Vasiliki ^a   Papathanasiou, Afroditi A ^a   Capdevila, Oscar Sans ^b   Bhattacharjee, Rakesh ^b   Kim, Jinkwan ^b   Gourgoulianis, Konstantinos ^a   Zintzaras, Elias ^a,d  

^a UNIVERSITY OF THESSALY   (Greece)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoxemia; Inflammation; Obstructive sleep apnea; Oxidative stress; Sleep disordered breathing; Uric acid

Indexed keywords

CREATININE; URIC ACID;

AGE; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; EUROPE; FEMALE; GENDER; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SNORING; URIC ACID URINE LEVEL;

ANOXIA; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEMALE; GREECE; HUMANS; LINEAR MODELS; MALE; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; SNORING; UNITED STATES; URIC ACID;

EID: 77951626142     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2009.06.011     Document Type: Article

References (46)

1. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008, 52:686-717.
2. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
3. de la Eva R.C., Baur L.A., Donaghue K.C., Waters K.A. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 2002, 140:654-659.
4. Li A.M., Chan M.H., Chan D.F., Lam H.S., Wong E.M., So H.K., et al. Insulin and obstructive sleep apnea in obese Chinese children. Pediatr Pulmonol 2006, 41:1175-1181.
5. Gozal D., Capdevila O.S., Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008, 177:1142-1149.
6. Kaditis A.G., Alexopoulos E.I., Damani E., Karadonta I., Kostadima E., Tsolakidou A., et al. Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol 2005, 40:515-523.
7. Gozal D., Kheirandish-Gozal L., Serpero L.D., Sans Capdevila O., Dayyat E. Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation 2007, 116:2307-2314.
8. Ugur M.B., Dogan S.M., Sogut A., Uzun L., Cinar F., Altin R., et al. Effect of adenoidectomy and/or tonsillectomy on cardiac functions in children with obstructive sleep apnea. ORL J Otorhinolaryngol Relat Spec 2008, 70:202-208.
9. Apostolidou M.T., Alexopoulos E.I., Damani E., Liakos N., Chaidas K., Boultadakis E., et al. Absence of blood pressure, metabolic, and inflammatory marker changes after adenotonsillectomy for sleep apnea in Greek children. Pediatr Pulmonol 2008, 43:550-560.
10. Amin R., Anthony L., Somers V., Fenchel M., McConnell K., Jefferies J., et al. Growth velocity predicts recurrence of sleep-disordered breathing 1year after adenotonsillectomy. Am J Respir Crit Care Med 2008, 177:654-659.
11. Kaditis A. Blood pressure after adenotonsillectomy in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2008, 178:882.
12. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 2003, 7:35-51.
13. Gozal D., Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008, 177:369-375.
14. Dyugovskaya L., Lavie P., Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002, 165:934-939.
15. Jelic S., Padeletti M., Kawut S.M., Higgins C., Canfield S.M., Onat D., et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008, 117:2270-2278.
16. O'Brien L.M., Serpero L.D., Tauman R., Gozal D. Plasma adhesion molecules in children with sleep-disordered breathing. Chest 2006, 129:947-953.
17. Montgomery-Downs H.E., Krishna J., Roberts L.J., Gozal D. Urinary F(2)-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep Breath 2006, 10:211-215.
18. Gozal D., Lipton A.J., Jones K.L. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002, 25:59-65.
19. Kaditis A.G., Alexopoulos E.I., Karadonta I., Kostadima E., Kiropoulos T., Gourgoulianis K., et al. Obstructive sleep-disordered breathing and plasma levels of vascular endothelial growth factor in children. Respir Med 2006, 100:835-840.
20. Kaditis A.G., Alexopoulos E.I., Kalampouka E., Hatzi F., Karadonta I., Kyropoulos T., et al. Nocturnal change of circulating intercellular adhesion molecule 1 levels in children with snoring. Sleep Breath 2007, 11:267-274.
21. Tauman R., Ivanenko A., O'Brien L.M., Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004, 113:e564-e569.
22. Tauman R., O'Brien L.M., Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath 2007, 11:77-84.
23. Li A.M., Chan M.H., Yin J., So H.K., Ng S.K., Chan I.H., et al. C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol 2008, 43:34-40.
24. Kaditis A.G., Alexopoulos E.I., Kalampouka E., Kostadima E., Germenis A., Zintzaras E., et al. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005, 171:282-286.
25. Tam C.S., Wong M., McBain R., Bailey S., Waters K.A. Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health 2006, 42:277-282.
26. Glantzounis G.K., Tsimoyiannis E.C., Kappas A.M., Galaris D.A. Uric acid and oxidative stress. Curr Pharm Des 2005, 11:4145-4151.
27. Sahebjani H. Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure. Chest 1998, 113:1604-1608.
28. McKeon J.L., Saunders N.A., Murree-Allen K., Olson L.G., Gyulay S., Dickeson J., et al. Urinary uric acid:creatinine ratio, serum erythropoietin, and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea. Am Rev Respir Dis 1990, 142:8-13.
29. Verhulst S.L., Van Hoeck K., Schrauwen N., Haentjens D., Rooman R., Van Gaal L., et al. Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. Chest 2007, 132:76-80.
30. National Center for Health Statistics. CDC Growth Charts: United States. National Health and Nutrition Examination Survey: Centers for Disease Control and Prevention; 2000.
31. Ogden C.L., Flegal K.M., Carroll M.D., Johnson C.L. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002, 288:1728-1732.
32. Larkin E.K., Rosen C.L., Kirchner H.L., Storfer-Isser A., Emancipator J.L., Johnson N.L., et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005, 111:1978-1984.
33. Gozal D., Crabtree V.M., Sans Capdevila O., Witcher L.A., Kheirandish-Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med 2007, 176:188-193.
34. Findley L.J., Boykin M., Fallon T., Belardinelli L. Plasma adenosine and hypoxemia in patients with sleep apnea. J Appl Physiol 1988, 64:556-561.
35. Hasday J.D., Grum C.M. Nocturnal increase of urinary uric acid:creatinine ratio. A biochemical correlate of sleep-associated hypoxemia. Am Rev Respir Dis 1987, 135:534-538.
36. Braghiroli A., Sacco C., Erbetta M., Ruga V., Donner C.F. Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 1993, 148:173-178.
37. Kaditis A.G., Alexopoulos E.I., Damani E., Hatzi F., Chaidas K., Kostopoulou T., et al. Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol 2009, 44:38-45.
38. O'Brien L.M., Gozal D. Autonomic dysfunction in children with sleep-disordered breathing. Sleep 2005, 28:747-752.
39. Sies H. Oxidative stress: introductory remarks. Oxidative stress 1985, 1-2. Academic Press, London. H. Sies (Ed.).
40. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990, 87:9383-9387.
41. Bo S., Gambino R., Durazzo M., Ghione F., Musso G., Gentile L., et al. Associations between serum uric acid and adipokines, markers of inflammation, and endothelial dysfunction. J Endocrinol Invest 2008, 31:499-504.
42. Verhulst S.L., Schrauwen N., Haentjens D., Rooman R.P., Van Gaal L., De Backer W.A., et al. Sleep-disordered breathing and the metabolic syndrome in overweight and obese children and adolescents. J Pediatr 2007, 150:608-612.
43. Redline S., Storfer-Isser A., Rosen C.L., Johnson N.L., Kirchner H.L., Emancipator J., et al. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med 2007, 176:401-408.
44. Khalyfa A., Kaditis A., Boazza M., Sans Capdevila O., Kheirandish-Gozal L., Bhattacharjee R., et al. C reactive protein (CRP) gene polymorphisms in US and Greek children with suspected obstructive sleep apnea (OSA). Sleep 2009, A0277.
45. Peixoto M.R., Monego E.T., Jardim P.C., Carvalho M.M., Sousa A.L., Oliveira J.S., et al. Diet and medication in the treatment of hyperuricemia in hypertensive patients. Arq Bras Cardiol 2001, 76:463-472.
46. Del Rio A., Rodriguez-Villamil J.L. Metabolic effects of strict salt restriction in essential hypertensive patients. J Intern Med 1993, 233:409-414.